Theradiag SA and Biosynex SA announced the signing of a distribution agreement. An initial two-year distribution agreement was signed between THERADIAG and BIOSYNEX for the AMPLIQUICK SARS-CoV-2 PCR test from BIOSYNEX, which will be promoted in hospitals by THERADIAG, which benefits from a strong presence in hospitals, and in particular in the vast majority of University Hospitals. As an extension of this first contract, BIOSYNEX and THERADIAG intend to explore the possibilities of developing joint projects.